Antinociceptive effect of Nidularium procerum: a Bromeliaceae from the Brazilian coastal rain forest.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 15693712)

Published in Phytomedicine on January 01, 2005

Authors

F C Amendoeira1, V S Frutuoso, L M Chedier, A T Pearman, M R Figueiredo, M A C Kaplan, S M Prescott, P T Bozza, H C Castro-Faria-Neto

Author Affiliations

1: Laboratório de Imunofarmacologia, Departamento de Fisiologia e Farmacodinâmica, IOC, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Articles by these authors

Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 5.17

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14

Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today (1992) 3.06

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol (1991) 3.05

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest (2001) 3.01

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature (1995) 2.79

Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature (2000) 2.76

Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75

Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem (1993) 2.61

Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol (1991) 2.59

Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest (1985) 2.58

An enhanced immune response in mice lacking the transcription factor NFAT1. Science (1996) 2.55

Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51

Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21

Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta. Nature (1998) 2.20

Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci U S A (1986) 2.18

Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16

Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest (1995) 2.06

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region. J Biol Chem (2000) 2.05

Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A (1998) 1.97

Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem (1987) 1.93

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A (1996) 1.88

Inflammatory roles of P-selectin. J Clin Invest (1993) 1.87

Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest (1997) 1.87

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem (2001) 1.86

Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci U S A (2000) 1.85

Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol (1990) 1.84

Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem (2000) 1.77

Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. J Biol Chem (1999) 1.73

Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J Biol Chem (1991) 1.71

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest (1995) 1.66

The leukocyte integrins. J Biol Chem (2000) 1.65

LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol (2001) 1.64

Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J Biol Chem (1983) 1.59

Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J Biol Chem (1987) 1.55

Platelet-activating factor acetylhydrolases. J Biol Chem (1997) 1.51

Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest (1988) 1.51

Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling. Proc Natl Acad Sci U S A (2001) 1.51

Activation of human neutrophil phospholipase D by three separable mechanisms. FASEB J (1990) 1.50

An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem (1989) 1.48

Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem (1996) 1.47

Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun (1989) 1.46

Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem (1999) 1.46

Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest (1995) 1.44

Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem (1995) 1.44

Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr Biol (2001) 1.43

Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem (1989) 1.42

Molecular cloning of a novel human diacylglycerol kinase highly selective for arachidonate-containing substrates. J Biol Chem (1996) 1.39

Paradise revealed: first-class science rocked by the sound of the waves. Cell Death Differ (2010) 1.39

Discovery of an arachidonoyl coenzyme A synthetase in human platelets. J Biol Chem (1982) 1.36

Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem (1999) 1.35

Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation. Photomed Laser Surg (2006) 1.35

Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem (1998) 1.33

Molecular cloning and characterization of a novel human diacylglycerol kinase zeta. J Biol Chem (1996) 1.31

CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J Immunol (1994) 1.30

Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol (1998) 1.30

The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets. Arch Biochem Biophys (1982) 1.29

Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Biol Chem (1991) 1.29

Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. Ann N Y Acad Sci (1986) 1.28

Diacylglycerol kinase zeta regulates Ras activation by a novel mechanism. J Cell Biol (2001) 1.28

Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest (1997) 1.28

Adhesion and signaling in vascular cell--cell interactions. J Clin Invest (1996) 1.27

TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol (2001) 1.26

Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol (2000) 1.26

Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. J Immunol (1987) 1.25

Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res (1993) 1.25

Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem (1999) 1.25

Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. J Clin Invest (1995) 1.22

Biologically active oxidized phospholipids. J Biol Chem (1999) 1.21

Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol (1999) 1.21

Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost (2013) 1.21

Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem (1990) 1.20

Deep venous thrombosis of the upper extremity: a reappraisal. Circulation (1979) 1.20

Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20

Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem (1998) 1.19

Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol (1990) 1.17

The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J Biol Chem (1989) 1.16

Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. J Biol Chem (1987) 1.16

Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest (1997) 1.16

The effect of eicosapentaenoic acid on leukotriene B production by human neutrophils. J Biol Chem (1984) 1.15

Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest (1997) 1.12

Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res (2001) 1.12

Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proc Natl Acad Sci U S A (2001) 1.12

The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein. Trans Assoc Am Physicians (1992) 1.12

Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics (1998) 1.12

Bioactive phospholipid oxidation products. Free Radic Biol Med (2000) 1.11

Platelet-activating factor: a mediator for clinicians. J Intern Med (1995) 1.11

Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem (1992) 1.09

Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta (1996) 1.09

"Pseudo-pseudothrombophlebitis": ruptured popliteal cyst with deep venous thrombosis. N Engl J Med (1978) 1.08

Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res (2001) 1.07

Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Proc Natl Acad Sci U S A (1989) 1.06

Inherited predisposition to thrombosis. Cell (1993) 1.05

Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol (1998) 1.05

Shear stress activates cytosolic phospholipase A2 (cPLA2) and MAP kinase in human endothelial cells. Biochem Biophys Res Commun (1996) 1.05

Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan. Br J Pharmacol (1989) 1.05